2024-11-18 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs and services.  The cumulative return for UNH is 202.7%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 123.86%. The difference is 78.84%, placing it in the 49.79th percentile of its historical performance range relative to the S&P 500.  This suggests a strong outperformance, but the relative percentile indicates periods of closer alignment with the S&P 500 in the past.

**Alpha and Beta Analysis:**

| Year       | CAGR     | MDD  | Alpha | Beta | Cap(B) |
|------------|----------|------|-------|-------|--------|
| 2015-2017  | 129.6%   | 12.2% | 91.2% | 0.9   | 202.9  |
| 2016-2018  | 123.9%   | 18.6% | 91.6% | 0.9   | 229.3  |
| 2017-2019  | 90.5%    | 21.0% | 38.8% | 0.9   | 270.6  |
| 2018-2020  | 66.1%    | 35.3% | 18.8% | 1.1   | 322.7  |
| 2019-2021  | 116.2%   | 35.3% | 16.1% | 1.0   | 462.1  |
| 2020-2022  | 89.2%    | 35.3% | 65.6% | 0.9   | 487.9  |
| 2021-2023  | 57.0%    | 16.3% | 22.1% | 0.5   | 484.5  |
| 2022-2024  | 22.6%    | 18.8% | -5.3% | 0.5   | 545.9  |

The analysis shows consistent positive alpha (outperformance relative to the market)  except for the most recent period (2022-2024).  The beta generally hovers around 0.9, indicating a relatively low sensitivity to market movements.  However, the recent drop in both CAGR and alpha suggests potential headwinds.

**2. Recent Price Movement:**

* **Closing Price:** 592.23
* **5-Day Moving Average:** 606.23
* **20-Day Moving Average:** 581.38
* **60-Day Moving Average:** 583.88

The price is currently below its 5-day and 60-day moving averages, suggesting a short-term bearish trend.  However, it's above the 20-day moving average, which could indicate potential support.

**3. Technical Indicators and Expected Return:**

* **RSI:** 61.36 (Slightly above neutral; not overbought)
* **PPO:** 0.44 (Positive, suggesting bullish momentum)
* **Relative Strength Change (20-day):** 6.64 (+), indicating short-term upward momentum.
* **Expected Return (2+ years):** 36.83%  This is a significant outperformance compared to the S&P 500.  However, this is a projected return and not a guarantee. The closing price of 592.12 is slightly below the 5-day moving average, suggesting a recent minor pullback rather than a sharp drop or surge.


**4. Recent Financial Performance and Outlook:**

| Date       | EPS    | Revenue       |
|------------|--------|----------------|
| 2024-11-04 | 6.56   | $100.82 B      |
| 2024-08-09 | 4.58   | $98.86 B      |
| 2024-05-09 | -1.53  | $99.80 B      |
| 2023-11-06 | 6.31   | $92.36 B      |
| 2024-11-04 | 6.31   | $92.36 B      | *(Duplicate entry - likely a data error)*


There's a notable fluctuation in EPS, with a significant loss in Q2 2024.  The most recent EPS (6.56) needs to be compared against analyst expectations to fully assess performance.  Revenue remains strong and generally increasing.  Further investigation into the Q2 2024 loss is warranted.


**6. Financial Information:**

**1) Revenue and Profitability:**  Revenue is consistently high, with profit margins generally above 20%. A slight dip is observed in Q3 and Q4 2023, followed by a return to higher margins.

**2) Capital and Profitability:** Equity shows a general upward trend. ROE fluctuates, suggesting varying levels of profitability based on capital employed. The negative ROE in Q1 2024 is concerning and requires further analysis.


**7. News and Recent Issues:**

*(This section requires real-time data from sources like Shacknews, FINBOLD, and financial news outlets.  I cannot provide current news without access to live feeds.)*  A search for recent UNH earnings news and analyst opinions should be conducted to complete this section.  Look for information on the Q2 2024 loss,  management commentary on future prospects, and consensus analyst ratings.


**8. Summary:**

UNH has historically significantly outperformed the S&P 500.  However, recent performance (2022-2024) shows a decline in CAGR and a negative alpha, coupled with a Q2 2024 loss.  While revenue remains strong, the fluctuating profitability and negative ROE in Q1 2024 are cause for concern.  Current technical indicators suggest a neutral to slightly bullish short-term outlook.  A comprehensive analysis requires investigation into the reasons behind the Q2 2024 loss, an assessment of analyst expectations for the most recent earnings, and consideration of any recent news and market outlook.  The long-term outlook (2+ years), based on the provided expected return, remains positive relative to the S&P 500, but risk assessment is crucial given the recent financial performance fluctuations.


**9. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Always conduct thorough due diligence and consult with a financial advisor before making any investment decisions.
